Scientists released the first complete sequence of a human Y chromosome
On Aug. 23. 2023, researchers co-led by University of California, Santa Cruz Assistant Professor of Biomolecular Engineering Karen…
-
-
Aspirin can help prevent a second heart attack, but most don’t take it
On Aug. 22, 2023, a study led by researchers at Washington University School of Medicine in St. Louis…
-
CPRIT awarded more than $49 million to Texas institutions for cancer research and prevention
On Aug. 16, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had approved over…
-
Biotechnology | Disease | HIV | Influenza | Measles | Medicine | Plague | Polio | Therapeutics | Vaccine
The United Kingdom announced the Vaccine Development and Evaluation Centre
On Aug. 7, 2023, the United Kingdom Health and Security Agency announced the Vaccine Development and Evaluation Centre…
-
Biotechnology | Medicine | NIH | Therapeutics
Only 1 in 5 U.S. adults with opioid use disorder received medications to treat it in 2021
On Aug. 7, 2023, a National Institute of Health supported study found that in 2021, an estimated 2.5…
-
Henrietta Lacks’ family settled lawsuit with biotech company that used her cells without consent
On Aug. 1, 2023, more than 70 years after doctors at Johns Hopkins Hospital took Henrietta Lacks’ cervical…
-
Emergent BioSolutions awarded 10-Year BARDA contract valued at $704 million for Ebanga treatment for Ebola
On Jul. 31, 2023, Emergent BioSolutions announced that it was awarded a 10-year contract by the Biomedical Advanced…
-
Feinstein Institutes researchers first to use double neural bypass to restore movement in man living with quadriplegia
On Jul. 28, 2023, in a first-of-its-kind clinical trial, bioelectronic medicine researchers, engineers and surgeons at Northwell Healthﾒs…
-
SIGA announced U.S. Government procurement orders of approximately $138 million for oral and IV TPOXX
On Jul. 27, 2023, SIGA Technologies announced that the U.S. Department of Health and Human Services exercised procurement…
-
CIRM invested $50 million in clinical-stage research
On Jul. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $50.1 million to fund clinical-stage research…
-
Milestones in Diabetes
Milestones in Diabetes illustrates major milestones from the first administration of the hormone insulin in 1921 to a…
-
JAMA reported excess death rates for Republican and Democratic voters in Florida and Ohio during COVID-19 pandemic
On Jul. 24, 2023, the Journal JAMA reported there is evidence that Republican-leaning counties had higher COVID-19 death…
-
NIH released new atlas of human kidney cells to help unlock kidney disease research
On Jul. 19, 2023, the National Institute of Health announced that a nationwide research team had created the…
-
First case of Candida auris reported in Washington with local transmission suspected
On Jul. 19, 2023, the King County Department of Health issued a Health Advisory that Candida auris (C….
-
U.S. FDA approved Veklury (Remdesivir) for COVID-19 treatment in patients with Severe renal impairment
On Jul. 14, 2023, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) had approved a…
-
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | Therapeutics | Vaccine | Veterinary
UK Animal and Plant Health Agency reported asymptomatic human detections of influenza A (H5N1)
On Jul. 14, 2023, the UK Animal and Plant Health Agency reported that additional asymptomatic human detections of…
-
Biotechnology | Disease | FDA | Neurology | Therapeutics
FDA granted traditional approval for LEQEMBI (lecanemab-irmb) for the treatment of Alzheimer’s disease
On Jul. 6, 2023, Eisai and Biogen announced that the U.S. Food and Drug Administration (FDA) had approved the…
-
Biotechnology | Diagnostics | Disease | FDA | Rare Disease | Therapeutics
U.S. FDA approved BioMarin’s ROCTAVIAN, the first and only gene therapy for adults with severe hemophilia A
On Jun. 29, 2023, the U.S. Food and Drug Administration approved Roctavian, an adeno-associated virus vector-based gene therapy…
-
Breakthrough Gene Therapy Offers Hope for Severe Developmental Epilepsy in Children
On Jun. 27, 2023, researchers from Tel Aviv University announced they have developed an innovative gene therapy that…
-
CDC reported locally acquired malaria cases identified in Florida and Texas.
On Jun. 26, 2023, the Centers for Disease Control and Prevention (CDC) announced they were collaborating with U.S….
-
IHME reported global diabetes cases to soar from 529 million to 1.3 billion by 2050
On Jun. 22, 2023, the Institute for Health Metrics and Evaluation (IHME) reported that more than half a…
-
Biotechnology | Disease | FDA | Medicine | Therapeutics
U.S. FDA approved first gene therapy for treatment of patients with Duchenne Muscular Dystrophy
On Jun. 22, 2023, the U.S. Food and Drug Administration (FDA) approved Sarepta Therapeutics’s Elevidys, the first gene…
-
Donald Triplett, the 1st person diagnosed with autism, died at 89
On Jun. 17, 2023, the Mississippi man known as “Case 1,” the first person to be diagnosed with…
-
U.S. FDA permitted marketing of first COVID-19 at-home test using traditional premarket review process
On Jun. 6, 2023, the U.S. Food and Drug Administration (FDA) granted granted marketing authorization for the Cue COVID-19…
-
Milestones in Parkinson’s
Milestones in Parkinson’s illustrates advancements in the disease from James Parkinson’s essay on ‘shaking palsy’ to development of…
-
CIRM invested $10 million to build California Cell and Gene Therapy Manufacturing Network
On May 31, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $10 million to five facilities as…
-
World’s first birth after uterus transplantation with robot-assisted surgery alone
On May 26, 2023, the University of Gothenburg announced that for the first time worldwide, in yet another…
-
U.S. FDA approved Paxlovid, first oral antiviral for treatment of COVID-19 in adults
On May 25, 2023, the U.S. Food and Drug Administration (FDA) approved the oral antiviral Paxlovid (nirmatrelvir tablets…
-
Large study provided scientists with deeper insight into long COVID symptoms
On May 25, 2023, the National Institutes of Health (NIH) announced Initial findings from a study of nearly…
-
U.S. FDA approved new buprenorphine treatment option for opioid use disorder
On Mar. 23, 2023, the U.S. Food and Drug Administration (FDA) approved Braeburn pharmaceutical’s Brixadi (buprenorphine) extended-release injection…
